Verona Pharma is covered by the following analysts.
| Analyst | Institution |
|---|---|
|
Thomas Shrader PhD, CFA |
BTIG |
|
Edward Nash |
Canaccord |
|
Olivia Brayer |
Cantor |
|
Tara Bancroft, PhD |
Cowen |
|
Raghuram Selvaraju, PhD |
H.C. Wainwright |
|
Andrew Tsai |
Jefferies |
|
Yasmeen Rahimi, PhD |
Piper Sandler |
|
Boobalan Pachaiyappan, PhD |
Roth Capital |
|
Joon Lee, MD, PhD |
Truist Securities |
|
Sushila Hernandez |
Van Lanschot Kempen |
|
Tiago Fauth |
Wells Fargo |
|
Andy Chen, PhD, CFA |
Wolfe Research |
Verona Pharma (Nasdaq:VRNA) is focused on delivering our strategy and creating value for shareholders.
